Halozyme Therapeutics
HALO
#1997
Rank
A$12.70 B
Marketcap
$102.86
Share price
1.28%
Change (1 day)
65.82%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): A$0.84 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.01 Billion. , an increase over its 2023 earnings that were of A$0.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 A$0.88 B59.94%
2023 A$0.55 B39.94%
2022 A$0.39 B0.16%
2021 A$0.39 B92.2%
2020 A$0.20 B-278.96%
2019 -A$0.12 Billion-9.45%
2018 -A$0.13 Billion-229.51%
2017 A$97.73 M-160.48%
2016 -A$0.17 Billion216.03%
2015 -A$51.14 Million-52.86%
2014 -A$0.11 Billion-18.09%
2013 -A$0.14 Billion55.88%
2012 -A$84.96 Million169.94%
2011 -A$31.48 Million-63.44%
2010 -A$86.08 Million-7.19%
2009 -A$92.74 Million15.91%
2008 -A$80.01 Million83.89%
2007 -A$43.52 Million78.1%
2006 -A$24.44 Million16%
2005 -A$21.07 Million45.24%
2004 -A$14.51 Million682.42%
2003 -A$1.86 Million1659.12%
2002 -A$0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$48.41 M-94.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.11 B 2,176.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.95 Billion-206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.62 B 1,894.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.59 B 1,325.52%๐Ÿ‡ซ๐Ÿ‡ท France
A$27.66 B 3,030.68%๐Ÿ‡บ๐Ÿ‡ธ USA